Related Experiment Video
Updated: Jan 17, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
CMR-Derived Atrial Strain in the Prediction of Adverse Cerebrovascular Events After Myocardial Infarction
Riccardo Cau1, Carlotta Onnis2, Gianluca Pontone3
1Department of Radiology, Azienda Ospedaliero Universitaria (A.O.U.), Italy; University of Cagliari, Cagliari, Italy.
Insights
Cardiovascular magnetic resonance (CMR) can assess atrial strain in ST-segment elevation myocardial infarction (STEMI) patients. Lower left atrial (LA) reservoir and conduit strain predict cerebrovascular events, aiding risk stratification.
Area of Science:
- Cardiology
- Medical Imaging
- Neurology
Background:
- ST-segment elevation myocardial infarction (STEMI) patients face risks of cerebrovascular events.
- Atrial function, assessed via strain parameters, may influence stroke risk.
- Cardiovascular magnetic resonance (CMR) offers detailed cardiac imaging.
Purpose of the Study:
- To investigate the association between CMR-derived atrial strain parameters and new-onset cerebrovascular events in STEMI patients.
- To determine if left atrial (LA) reservoir, conduit, and booster strain predict cerebrovascular events post-STEMI.
- To evaluate the utility of atrial strain in risk stratification for STEMI survivors.
Main Methods:
- Retrospective analysis of 211 STEMI patients who underwent coronary revascularization.
- CMR scans assessed for left atrial (LA) reservoir, conduit, and booster strain using cine steady-state free precession sequences.
- Follow-up for cerebrovascular events (acute ischemic stroke or transient ischemic attack) analyzed using multivariable Cox regression.
Main Results:
- 23 patients (11%) experienced cerebrovascular events during a median 25-month follow-up.
- LA reservoir strain (HR: 0.84; p=0.001) and LA conduit strain (HR: 0.74; p=0.001) were independent predictors of cerebrovascular events.
- These associations remained significant after adjusting for cardiovascular risk factors, LA volume, thrombus, and atrial fibrillation.
Conclusions:
- CMR-derived LA reservoir and conduit strain are independently associated with an increased risk of cerebrovascular events in STEMI patients.
- These atrial strain parameters may serve as novel biomarkers for stroke risk.
- Integrating LA strain analysis into clinical assessment could enhance risk stratification for STEMI patients.
Abstract:
This study investigated whether cardiovascular magnetic resonance (CMR)-derived atrial strain parameters are associated with new-onset cerebrovascular events in patients with reperfused ST-segment elevation myocardial infarction (STEMI). In this retrospective analysis, CMR scans of 211 consecutive STEMI patients (77% male; mean age 64.5 ± 10.3 years) who underwent coronary revascularization were assessed. The primary endpoint was the occurrence of acute ischemic stroke or transient ischemic attack, collectively defined as cerebrovascular events. Atrial strain was analyzed offline from standard cine steady-state free precession sequences, focusing on left atrial (LA) reservoir, conduit, and booster strain. Over a median follow-up of 25 months (interquartile range 13-36), 23 patients (11%) experienced cerebrovascular events. In multivariable Cox regression analysis, LA reservoir and conduit strain were independent predictors of these events, irrespective of cardiovascular risk factors, LA volume, thrombus presence, and incident atrial fibrillation (HR: 0.84; 95% CI: 0.77-0.91; p = 0.001 and HR: 0.74; 95% CI: 0.63-0.87; p = 0.001, respectively). In conclusion, CMR-derived LA reservoir and conduit strain are independently associated with increased risk of cerebrovascular events, and their integration into the clinical assessment of STEMI patients may improve risk stratification.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy IV: Restrictive Cardiomyopathy

